Altchem Ltd - 18 Oct 2023 Form 4 Insider Report for RVL Pharmaceuticals plc

Role: 10%+ Owner
Signature: /s/MILITSA SYMEOU, Altchem Limited, by Militsa Symeou, its Director
Issuer symbol: N/A
Transactions as of: 18 Oct 2023
Net transactions value: -$221,031
Form type: 4
Filing time: 20 Oct 2023, 13:36:58 UTC
Next filing: 23 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVLP	Ordinary Shares	Sale	$221,031	-3,421,537	-15%	$0.0646	19,063,760	18 Oct 2023	Direct	F1
holding	RVLP	Ordinary Shares						1,182,243	18 Oct 2023	By Self as Sole Manager of Orbit Co-Invest A-1 LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a volume weighted average price. These shares were sold in multiple transactions at prices ranging from $0.0600 to $0.0678, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Represents shares of the Issuer held by Orbit Co-Invest A-1 LLC. Altchem Limited is the sole manager of Orbit Co-Invest A-1 LLC. As a result, Altchem Limited may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest A-1 LLC. Altchem Limited disclaims beneficial ownership of such shares and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.

Content

The price reported in Column 4 is a volume weighted average price. These shares were sold in multiple transactions at prices ranging from $0.0600 to $0.0678, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents shares of the Issuer held by Orbit Co-Invest A-1 LLC. Altchem Limited is the sole manager of Orbit Co-Invest A-1 LLC. As a result, Altchem Limited may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest A-1 LLC. Altchem Limited disclaims beneficial ownership of such shares and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.